• Explore /
  • Poster
  • / Real-world (RW) effectiveness of nivolumab plus chemotherapy (NIVO+chemo) in patients (pts) with advanced or metastatic gastric carcinoma, gastroesophageal junction carcinoma, or esophageal adenocarcinoma (GC/GEJC/EAC).

Real-world (RW) effectiveness of nivolumab plus chemotherapy (NIVO+chemo) in patients (pts) with advanced or metastatic gastric carcinoma, gastroesophageal junction carcinoma, or esophageal adenocarcinoma (GC/GEJC/EAC).

Abstract Poster

Authors

Ian Chau

Ian Chau

The Royal Marsden NHS Foundation Trust, London, United Kingdom

Ian Chau , Afsaneh Barzi , Ying Zhang , Min You , David Bertwistle , Catherine Davis , Clara Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Quality of Care/Quality Improvement

Clinical Trial Registration Number

NCT02872116

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 295)

DOI

10.1200/JCO.2024.42.3_suppl.295

Abstract #

295

Poster Bd #

D15

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Exploring real-world outcomes with nivolumab plus chemotherapy in patients with advanced gastroesophageal adenocarcinoma.

Exploring real-world outcomes with nivolumab plus chemotherapy in patients with advanced gastroesophageal adenocarcinoma.

First Author: Clara Chen

First Author: Lin Shen

First Author: Yelena Y. Janjigian